Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hexosaminidase M is a specialized glycosyl hydrolase, primarily identified in microbial species such as Streptomyces, that belongs to the glycosyl hydrolase family 20. It functions as an exochitinase, catalyzing the hydrolysis of terminal, non-reducing N-acetyl-D-hexosamine residues from chitin-derived oligosaccharides and glycoconjugates. In a therapeutic context, Hexosaminidase M and its homologs are studied as potential targets for antimicrobial and antifungal agents, as inhibiting these enzymes can disrupt the degradation of chitin, a vital structural component of fungal cell walls and arthropod exoskeletons. While it shares structural similarities with human lysosomal hexosaminidases, its specific substrate preference and microbial origin make it a subject of interest for developing selective inhibitors. Research into this enzyme also extends to industrial applications, such as the conversion of chitinous waste into value-added products like N-acetylglucosamine.
Competitive inhibition of the enzyme's active site to prevent the hydrolysis of chitin-derived oligosaccharides, thereby disrupting microbial cell wall integrity or nutrient acquisition.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hexosaminidase M (HexM).